WEST HARTFORD, Conn. (WTNH) – When you think of health care, there can be many different stages of treatment including seeing a doctor, picking up a prescription, and a possible follow-up appointment with another type of medical professional. That could be the system of the past soon.
The University of St. Joseph is getting federal money that will go to a new program with an emphasis on collaborative learning. The $900,000 Connecticut Horizons Grant will bring students from multiple disciplines together including nurses, pharmacists, social workers, and more.
The idea is to move away from fragmented care and teach the next generation of medical professionals how to work with each other as a team.
“This will provide the University of St. Joseph an opportunity to really ground it into the curriculum and provide it to most of the students in these programs,” said Janet Knecht, Chair of the Department of Nursing at the University of St. Joseph.
“When you’re in the hospital today, you’re not being taken care of by one professional, right,” Senator Chris Murphy asked. “You’ve got a team. Part of education for health care professionals has to be teamwork.”
The program is for both undergraduate and graduate students.
“I have been an American Heart Association (AHA) instructor for more than 10 years but training on the HeartCode Complete platform has been a very rewarding experience. I could complete cognitive and psychomotor skill sessions at my own time and convenience. What would normally take a full day of classroom sessions was completed in 35-40 minutes,” says Dr Meghna Mukund, Associate Professor of Anaesthesiology and Chief Coordinator for Skills Lab at Yenepoya Medical College Hospital, which has appointed MedLern as its learning partner.
A digital learning solution for hospitals and healthcare professionals, MedLern serves healthcare training needs in hospitals, colleges and for individual professionals.
As published in Edugraph, MedLern launches innovative, online resuscitation training in India states that Yenepoya Mangalore (deemed to be University) is the first university in India to adopt this programme.
Co-developed by the American Heart Association and Laerdal Medical, the HeartCode Complete Program combines adaptive online learning with hands-on skills training to deliver cardiopulmonary resuscitation (CPR) training across organisations.
The Medical Council of India (MCI) has made it mandatory for doctors to complete 30 hours of CME (Continuing Medical Education) every five years to renew their licence by attending workshops and seminars, which are organised by various healthcare institutions in India.
CME helps medical and health professionals engage in activities designed to support their continuing professional development.
In her 2017 article, Online medical education gaining momentum in India, published in ETHealthWorld, Priyanka V Gupta writes that according to a 2002 WHO study, Promoting Rational Use of Medicines, CME opportunities are limited in developing countries like India, unlike developed countries like the US.
Although popular globally, online CME is still in its rudimentary stage in India.
One of the challenges is the fact that the MCI is yet to recognise online medical education content. This means that a student passing a course at an online CME platform can’t practise but can assist a medical practitioner. So, there continues to be a cardinal difference between formal medical education and add-on medical educational learning support, as provided by CME players.
However, it seems the pandemic changed the evolving CME conversation.
The doctor-population ratio in India is 1:1456 against the World Health Organisation (WHO) recommendation of 1:1000, according to the Economic Survey 2019-20.
This signals the need for validated online CME platforms to ensure last-mile delivery of upgraded medical education content, bridging barriers of distance and time. This also perhaps suggests that an online mode of CME can help medical practitioners stay abreast with developments in their field.
If before COVID, a leading live CME platform like Clirnet had 25,000 doctors, the pandemic led to an overhaul.
“COVID changed everything. Nobody knew anything about the disease; nothing was available in medical journals. So, during the first three months of 2020, all clinical experiences doctors were amassing were circulated in the entire medical community,” says Saurav Kasera, Co-founder of Kolkata-based Clirnet, a doctor-generated content platform founded in 2018.
He adds that the platform has witnessed an aggressive surge in doctor enrolment in the past three years, with the number shooting up to 250,000 from a mere 25,000 pre-COVID.
“On an average, around 8,000-10,000 doctors join our platform every month. By this year-end, we expect the numbers to be around 300,000, and around 350,000 by next June,” Saurav says.
However, the aim is not to mindlessly gain numbers but to target doctors with meaningful content. Doctors join the platform as it addresses their need to stay updated.
Saurav credits this growth to the platform’s digital partnership with several medical associations, which has helped Clirnet gain credibility and enjoy traction among the medical community.
In fact, the platform now has a deep COVID content bank, with “infectious diseases” one of the fastest-growing focus areas. “Most people didn’t even know that there are infectious diseases certified before the pandemic,” Saurav says.
Describing how the platform was born with a passion to discuss real-world medicine, he gives an example. Consider an oncologist in Ziro, Arunachal Pradesh, treating a cancer patient. A report, released by the Indian Council of Medical Research (ICMR) and National Centre for Disease Informatics and Research (NCDIR), stated that Papumpare district in Arunachal Pradesh recorded 219.8 per one lakh cancer cases among females. Meanwhile, a 2021 news report in Times of India called the Northeast the “cancer capital” of India, recording the highest age-adjusted cancer incidence rates of newly diagnosed cancer cases.
Saurav says the Ziro oncologist - previously only in contact with friends and fellow oncologists in Guwahati and Kolkata - could now make valuable interactions with counterparts in Delhi and Mumbai.
Given the way diseases and medical science are evolving, a doctor from Hapur in Uttar Pradesh can learn from one in Kolkata and vice versa, Saurav says, disrupting the notion of hierarchies woven in the urban-versus-rural discourse.
Elaborating on the Ziro example, Saurav says the platform’s vision is that the local doctor should help a patient access the collective wisdom of doctors, or the “software of healthcare”.
To provide an idea of the volume, he says every month Clirnet has 40,000 doctors discussing diverse medical problems, and sharing clinical knowledge, experiences, and new developments.
As per Deccan Herald’s 2021 article, How Doctors Can Earn Continuing Medical Education Credits, some private players like Omnicuris offer CME courses that are approved by the MCI. Its portal lists around 209 CME courses and it has tied up with 12+ state governments.
For online CME players, producing globally accepted content remains a market challenge.
A platform like MedLern provides CME courses to diverse healthcare professionals such as doctors, nurses, paramedics, allied health professionals, home care, physiotherapy, laboratory and emergency workers, technicians, and people in front office operations, hospital management, and quality control.
Experts suggest that apart from credibility, acceptability of online medical education continues to be a barrier among medicos.
Most doctors have hectic lifestyles, which is why peer-to-peer physical conferences have long been popular – they let the medical professionals upgrade and fraternise.
Even if one argues that getting answers for a specific patient case has a faster turnaround on a digital platform, why would a doctor first not reach out to their vetted communities/peer groups a call/text away? How does a CME platform solve that problem?
Dr Priya Ganesh, Clinical Advisor, Women’s Health, GenWorks Health, says, “Doctors with their busy schedule would definitely like to have an upgradation of their skill sets and knowledge. With new things coming up, a digital platform is one click away to reach out to the community.”
Unlike lay audiences or several other professionals, doctors are a learned target audience. To ensure that the platform targets these super-busy professionals with the right content, Clirnet leverages artificial intelligence (AI) enabled technology.
The content engagement mechanism, which Saurav describes as “intelli-targeting”, intelligently targets doctors on the basis of the “discovery” of their browsing behaviour, personality traits, usage, and consumption patterns through AI. It is geared towards curating individualised content, and the tech provides “minimal but meaningful touch points” for positive patientcare outcomes.
Dr Priya says that COVID-19 has made the medical community well versed with online CME, which when conducted physically previously although successful was limited in its reach.
The smartphone and data revolution has led to deeper internet penetration in Tier II and Tier III India, which is also helping medical practitioners. They are now more receptive to digital modules such as webinars and video conferencing interfaces such as Zoom and Microsoft Teams.
“Not everyone is lucky enough to enjoy the facility of a corporate hospital where you have a counsellor. So ultimately, a doctor himself has to take out time to talk. This is where the dissemination of information using technology for public awareness on courses as diverse and as significant as male infertility, polycystic ovarian disease (PCOD), adolescent health, menstrual hygiene, cancer awareness, self-breast examination in layman language is important,” Priya says.
Talking about “Google era” patients, says most patients now visit doctors with some preparation, which makes disseminating authentic knowledge equally critical for medical practitioners and patients.
MedLern claims to bring high quality healthcare training and skilling resources to diverse healthcare professionals and settings — from large multi-city hospital chains in major cities to sub-50 bed hospitals in Tier II and Tier III cities.
“We are currently in 310 hospitals and 50 colleges, with a small footprint in the Middle East, and cover over 83,000 healthcare professionals,” says Deepak Sharma, CEO, MedLern.
Meanwhile, GenWorks has, for the last one and a half years, been conducting webinars to target Tier II and Tier III demographics and disseminate knowledge about cervical cancer prevention, HPV (human papillomavirus) vaccination etc.
“More than 15,000 doctors have attended these webinar sessions so far,” Priya says. Had it been the past era where doctors had to physically travel, they would have seen one-tenth of these numbers, and even those one-tenth would be the key opinion leaders (KOLs) themselves, she adds.
Deepak says MedLern has created tailored programmes in healthcare settings in specific areas like critical care, patient safety, service excellence, infection control and quality management.
“These are delivered through e-learning, expert-led classrooms and simulation-based skill modules combined with rigorous assessments to measure impact.”
Saurav of Clirnet credits the commitment of the medical community, as there are doctors who due to a time constraint make the effort to share any new observation in their field in a self-recorded video to be posted on the platform. The motto is to ensure “information outreach is democratised”.
While the CME space is abuzz several interventions, only time will tell how it is able to critically disseminate information with authenticity, nuance, and ethics, and impact last-mile delivery.
(The copy was updated to correct a typo.)
NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Salience Learning, a learning and development firm focused on the life science industry, has launched a new version of Generating Insights Academy, part of a series of academies that build essential capabilities for professionals in life science organizations. Initially, Generating Insights Academy was only available for medical affairs personnel within biopharmaceutical companies. Now, its content is also customized to market access professional roles.
Generating Insights Academy is part of a suite of role-tailored Capability Academies offered by Salience Learning, including:
Salience Learning started developing the academies when customers asked for training programs that went beyond finite skills and technical knowledge. They wanted to develop broader capabilities to drive performance.
Krista Gerhard, a Partner at Salience Learning, said, "For many, generating Insights is key to being more strategic and effective. Regardless of their roles, life science professionals face large volumes of information, making it harder to identify meaningful insights. This academy demystifies the process, enabling learners to generate insights more effectively. Expanding this academy for market access and field-based roles provides a capability differentiator and sets an organization up for continuous innovation."
"Many people think insights have to develop organically, but that's not true. People can learn to generate insights purposefully, and this academy uses proven techniques to help them do that. We believe the ability to meaningfully generate insights is a competitive advantage, and we're excited to offer this to customers," shared Karen Foster, learning architect for the academy.
Tailored versions of all Capability Academies are available for home office and field-based roles across Medical, Commercial, and Market Access functions. Like all academies in the suite, Generating Insights Academy can be delivered as a digital or blended learning experience and incorporates micro-, spaced, and social-learning design elements.About Salience Learning
Salience Learning (www.saliencelearning.com) is a learning and development (L&D) firm that empowers change across the life science industry through learning. Its team of adult education experts and experienced biopharma professionals apply science-based educational approaches to help solve the industry's most complex business challenges. The firm offers a series of role-specific academies that develop critical capabilities for industry professionals. It also develops custom learning solutions and provides strategic consulting services in L&D. Salience Learning serves clients globally.
For more information, contact:
View original content to get multimedia:https://www.prnewswire.com/news-releases/salience-learnings-generating-insights-academy-now-available-for-market-access-roles-301643440.html
SOURCE Salience Learning
The vast majority of FDA-approved medical devices enabled by artificial intelligence or machine learning are concentrated in radiology and cardiovascular care, according to an analysis by Rock Health.
Rock Health used data from FDA clearances and approvals from 1997 to 2021 to determine where these devices are used the most.
Here are the AI/machine-learning enabled devices by therapeutic area, the Oct. 8 report found:
1. Radiology: 70 percent
2. Cardiovascular: 12 percent
3. Hematology: 4 percent
4. Neurology: 4 percent
6. Clinical chemistry
7. General and plastic surgery
The MarketWatch News Department was not involved in the creation of this content.
Oct 14, 2022 (The Expresswire) -- As per latest research, the growth of Medical Simulation market size was valued at USD 1439.34 million in 2021 and is expected to expand at a CAGR of 12.39% during the forecast period, reaching USD 2900.77 million by 2027.
Medical Simulation Market is expected to reach multi million by 2027, In valuation to 2021, Over the few years the Medical Simulation Market will reach a magnificent spike in CAGR in terms of revenue.
Medical Simulation Market Analysis Consist data of 2022-2027:
The global Medical Simulation market size was valued at USD 1439.34 million in 2021 and is expected to expand at a CAGR of 12.39% during the forecast period, reaching USD 2900.77 million by 2027.
Medical simulation, or Healthcare Simulation, is the modern day methodology for training healthcare professionals through the use of advanced educational technology. Simply put, medical simulation is the experiential learning every healthcare professional will need, but cannot always engage in during real-life patient care. Medical simulation has also been called healthcare simulation, simulation in healthcare, patient simulation, nursing simulation, surgical simulation, and clinical simulation.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Medical Simulation market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers and acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Medical Simulation Market Effect Factor Analysis.● Technology Process/Risk Considering Substitute Threat and Technology Progress InMedical Simulation Industry. ● Medical Simulation Market research contains an in-depth analysis of report complete data on factors influencing demand, growth, opportunities, challenges, and restraints, and Analysis of Pre and Post COVID-19 Market.
Who Are Medical Simulation Market Key Manufacturers?● Along with this survey you also get their Product Information Types (Digital Simulators, AR (VR) Simulators), Applications (Academic Institutes and Research Centers, Hospitals and Clinics, Military Organizations), and Specification. Detailed profiles of the Top major players in the industry:CAE, Inc., Oxford Medical Simulation Ltd., GIBLIB, SimX Inc., Ingmar Medical, Medical Simulation Corporation, 3D Systems, Conquer Mobile, Sensus3D, Medusims, Laerdal Medical, Cardionics, Inc., Immersus
What Overview Medical Simulation Market Says?● This Overview Includes Diligent Analysis of Scope, Types, Application, Sales by region, types and applications. ● Medical Simulation Market, USD Forecast till Medical Simulation
What Is Medical Simulation Market Competition● considering Manufacturers, Types and Application? Based on Thorough Research of Key Factors
Medical Simulation Market Manufacturing Cost Analysis● This Analysis is done by considering prime elements like Key RAW Materials, Price Trends, Market Concentration Rate of Raw Materials, Proportion of Raw Materials and Labour Cost in Manufacturing Cost Structure. ● Political/Economical Change. with unexpected CAGR during the forecast period. ● Medical Simulation Market size is expected to extent multi million by Medical Simulation, in comparison to 2022
What are Industry Insights?
The Global Medical Simulation market is expected to rise at a considerable rate during the forecast period, between 2022 and Medical Simulation. In 2021, the market is rising at a steady rate and with the expanding adoption of strategies by key players, the market is expected to rise over the projected horizon.
The Major players covered in the Medical Simulation market report are:
● CAE, Inc.
● Oxford Medical Simulation Ltd.
● SimX Inc.
● Ingmar Medical
● Medical Simulation Corporation
● 3D Systems
● Conquer Mobile
● Laerdal Medical
● Cardionics, Inc.
Get a demo PDF of report -https://www.marketgrowthreports.com/enquiry/request-sample/21404250
Moreover, it helps new businesses perform a positive assessment of their business plans because it covers a range of courses market participants must be aware of to remain competitive.
Medical Simulation Market Report identifies various key players in the market and sheds light on their strategies and collaborations to combat competition. The comprehensive report provides a two-dimensional picture of the market. By knowing the global revenue of manufacturers, the global price of manufacturers, and the production by manufacturers during the forecast period of 2022 to Medical Simulation, the reader can identify the footprints of manufacturers in the Medical Simulation industry.
Medical Simulation Market - Competitive and Segmentation Analysis:
As well as providing an overview of successful marketing strategies, market contributions, and exact developments of leading companies, the report also offers a dashboard overview of leading companies' past and present performance. Several methodologies and analyses are used in the research report to provide in-depth and accurate information about the Medical Simulation Market.
The current market dossier provides market growth potential, opportunities, drivers, industry-specific challenges and risks market share along with the growth rate of the global Medical Simulation market. The report also covers monetary and exchange fluctuations, import-export trade, and global market
status in a smooth-tongued pattern. The SWOT analysis, compiled by industry experts, Industry Concentration Ratio and the latest developments for the global Medical Simulation market share are covered in a statistical way in the form of tables and figures including graphs and charts for easy understanding.
Research report world follows a primary and secondary methodology that involves data based on top-down, bottom-up approaches, and validation of the estimated numbers through research. The information used to estimate market size, share, and forecast of various segments-sub segments at the global, country level, regional level is derived from the unique sources and the right stakeholders.
Medical Simulation Market Growth rate or CAGR exhibited by a market certain forecast period is calculate on the basic types, application, company profile and their impact on the market. Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia, etc. Paid data sources include third-party authentic industry databases.
On the basis of product typethis report displays the production, revenue, price, market share and growth rate of each type, primarily split into:
● Digital Simulators
● AR (VR) Simulators
On the basis of the end users/applicationsthis report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:
● Academic Institutes and Research Centers
● Hospitals and Clinics
● Military Organizations
Inquire more and share questions if any before the purchase on this report at-https://www.marketgrowthreports.com/enquiry/pre-order-enquiry/21404250
Target Audience of Medical Simulation Market:● Manufacturer / Potential Investors ● Traders, Distributors, Wholesalers, Retailers, Importers and Exporters. ● Association and government bodies.
Medical Simulation Market - Regional Analysis:
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Medical Simulation in these regions, from 2015 to 2027, covering● North America (United States, Canada and Mexico) ● Europe (Germany, UK, France, Italy, Russia and Turkey etc.) ● Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam) ● South America (Brazil, Argentina, Columbia etc.) ● Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Some of the key questions answered in this report:● What is the global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) sales value, production value, consumption value, import and export of Medical Simulation? ● Who are the global key manufacturers of the Medical Simulation Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)? ● How the competition goes in the future related to Medical Simulation? ● Which is the most leading country in the world? ● What are the Medical Simulation market opportunities and threats faced by the vendors in the global Medical Simulation Industry? ● Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application? ● What focused approach and constraints are holding the Medical Simulation market? ● What are the different sales, marketing, and distribution channels in the global industry? ● What are the upstream raw materials and manufacturing equipment of Medical Simulation along with the manufacturing process of Acetonitrile? ● What are the key market trends impacting the growth of the Medical Simulation market? ● Economic impact on the Medical Simulation industry and development trend of the Medical Simulation industry. ● What are the market opportunities, market risk, and market overview of the Medical Simulation market? ● What are the key drivers, restraints, opportunities, and challenges of the Medical Simulation market, and how they are expected to impact the market? ● What is the Medical Simulation market size at the regional and country-level?
Get a demo PDF of report -https://www.marketgrowthreports.com/enquiry/request-sample/21404250
Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.
With tables and figures helping analyse worldwide Global Medical Simulation market trends, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Detailed TOC of Global Medical Simulation Market Research Report 2022
1Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2.1 World Market Overview
2.1.1 Global Medical Simulation Annual Sales 2017-Medical Simulation
2.1.2 World Current and Future Analysis for Medical Simulation by Geographic Region, 2017, 2022 andMedical Simulation
2.1.3 World Current and Future Analysis for Medical Simulation by Country/Region, 2017, 2022 andMedical Simulation
2.2 Medical Simulation Segment by Type
2.3 Medical Simulation Sales by Type
2.3.1 Global Medical Simulation Sales Market Share by Type (2017-2027)
2.3.2 Global Medical Simulation Revenue and Market Share by Type (2017-2027)
2.3.3 Global Medical Simulation Sale Price by Type (2017-2027)
2.4 Medical Simulation Segment by Applications
2.5 Medical Simulation Sales by Application
2.5.1 Global Medical Simulation Sale Market Share by Application (2017-2027)
2.5.2 Global Medical Simulation Revenue and Market Share by Application (2017-2027)
2.5.3 Global Medical Simulation Sale Price by Application (2017-2027)
3Global Medical Simulation by Company
3.1 Global Medical Simulation Breakdown Data by Company
3.1.1 Global Medical Simulation Annual Sales by Company (2020-2022)
3.1.2 Global Medical Simulation Sales Market Share by Company (2020-2022)
3.2 Global Medical Simulation Annual Revenue by Company (2020-2022)
3.2.1 Global Medical Simulation Revenue by Company (2020-2022)
3.2.2 Global Medical Simulation Revenue Market Share by Company (2020-2022)
3.3 Global Medical Simulation Sale Price by Company
3.4 Key Manufacturers Medical Simulation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Simulation Product Location Distribution
3.4.2 Players Medical Simulation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) and (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion
4World Historic Review for Medical Simulation by Geographic Region
4.1 World Historic Medical Simulation Market Size by Geographic Region (2017-2027)
4.1.1 Global Medical Simulation Annual Sales by Geographic Region (2017-2027)
4.1.2 Global Medical Simulation Annual Revenue by Geographic Region
4.2 World Historic Medical Simulation Market Size by Country/Region (2017-2027)
4.2.1 Global Medical Simulation Annual Sales by Country/Region (2017-2027)
4.2.2 Global Medical Simulation Annual Revenue by Country/Region
4.3 Americas Medical Simulation Sales Growth
4.4 APAC Medical Simulation Sales Growth
4.5 Europe Medical Simulation Sales Growth
4.6 Middle East and Africa Medical Simulation Sales Growth
5.1 Americas Medical Simulation Sales by Country
5.1.1 Americas Medical Simulation Sales by Country (2017-2027)
5.1.2 Americas Medical Simulation Revenue by Country (2017-2027)
5.2 Americas Medical Simulation Sales by Type
5.3 Americas Medical Simulation Sales by Application
5.4 United States
6.1 APAC Medical Simulation Sales by Region
6.1.1 APAC Medical Simulation Sales by Region (2017-2027)
6.1.2 APAC Medical Simulation Revenue by Region (2017-2027)
6.2 APAC Medical Simulation Sales by Type
6.3 APAC Medical Simulation Sales by Application
6.6 South Korea
6.7 Southeast Asia
6.10 China Taiwan
7.1 Europe Medical Simulation by Country
7.1.1 Europe Medical Simulation Sales by Country (2017-2027)
7.1.2 Europe Medical Simulation Revenue by Country (2017-2027)
7.2 Europe Medical Simulation Sales by Type
7.3 Europe Medical Simulation Sales by Application
8Middle East and Africa
8.1 Middle East and Africa Medical Simulation by Country
8.1.1 Middle East and Africa Medical Simulation Sales by Country (2017-2027)
8.1.2 Middle East and Africa Medical Simulation Revenue by Country (2017-2027)
8.2 Middle East and Africa Medical Simulation Sales by Type
8.3 Middle East and Africa Medical Simulation Sales by Application
8.5 South Africa
8.8 GCC Countries
9Market Drivers, Challenges and Trends
9.1 Market Drivers and Growth Opportunities
9.2 Market Challenges and Risks
9.3 Industry Trends
10Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Simulation
10.3 Manufacturing Process Analysis of Medical Simulation
10.4 Industry Chain Structure of Medical Simulation
11Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Simulation Distributors
11.3 Medical Simulation Customer
12World Forecast Review for Medical Simulation by Geographic Region
12.1 Global Medical Simulation Market Size Forecast by Region
12.1.1 Global Medical Simulation Forecast by Region (2023-Medical Simulation)
12.1.2 Global Medical Simulation Annual Revenue Forecast by Region (2023-Medical Simulation)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East and Africa Forecast by Country
12.6 Global Medical Simulation Forecast by Type
12.7 Global Medical Simulation Forecast by Application
13Key Players Analysis
13.1.1 Company Information
13.1.2 Medical Simulation Product Offered
13.1.3 Medical Simulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Main Business Overview
13.1.5 Latest Developments
14Research Findings and Conclusion
Purchase this report (Price 3250 USD for a single-user license)-https://www.marketgrowthreports.com/purchase/21404250
Market Growth Reports
Phone: US + 1 424 253 0807
UK + 44 203 239 8187
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Global Medical Simulation Market Size in 2022, Growth Analysis, Key Players, Share, Revenue, Trends and emerging technology with Forecast till 2027
The MarketWatch News Department was not involved in the creation of this content.
TRI-COUNTY, S.C. (CN2 NEWS) – Student athletes are back in the classroom and on the field this school year. While they’re panic about who they play next, Some are more concerned for their safety.
Concussions can be an unfortunate part of many sports but health professionals say just because they’re common, doesn’t mean it’s worth playing through.
On this night of much loved Friday night football, CN2’s Zane Cina learning what concussions look like and how to prevent them.
Approximately 12-14 years and $2.6 billion dollars are needed to create and launch a new drug. The first step to achieving this is the drug discovery stage. It usually takes about four years and, in the case of small molecule therapeutics, necessitates more than 4,000 compounds to be manufactured and screened.
Organizations need a transformational method for drug discovery to speed up the innovation cycle, advance drug candidates to the clinical stage more rapidly, and boost competitiveness.
They must create advanced new therapeutics for rare diseases faster, reduce experimental timelines and costs, and decrease the failure rate of drug candidates in the clinical stages.
Drug Discovery transformation necessitates an integrated drug discovery workflow that blends in silico and experimental methods (or the “Virtual” and the “Real” (“V+R”)).
BIOVIA has developed an integrated, dedicated solution for Small Molecule Therapeutics Design that incorporates all capabilities for V and R relevant to an advanced discovery organization.
It includes capabilities to design and carry out physical lab experiments, record results gathered, and register the molecules efficiently and seamlessly. This boosts lab productivity and reduces R-cycles. Incorporating in silico approaches like molecular modeling and machine learning (ML) will offer the required insight into intermolecular systems.
Artificial intelligence (AI) helps scientists identify which compounds to synthesize next to help them reach a desired target product profile; while taking into account activity, ADME, anti-target effect, and toxicology profiles. Sharing validated models to the discovery team extends modeling specialists' reach.
The V-cycle — the computerized virtual creation, testing, and selection of unique small molecules — helps to design and create drug candidates with superior efficiency, safety profiles, and lower costs.
To launch AI-driven Drug Design as a practice within a discovery organization, all facets of this process and people involved must use fully integrated applications built on a backbone of collective informatics.
Figure 1. By combining physical testing in the lab (real) with in silico (virtual) in an iterative way, organizations can speed the drug discovery process by as much as 50%, by 1) reducing the number of active learning cycles and 2) shortening the time for each active learning cycle. Image Credit: BIOVIA, Dassault Systèmes
Figure 2. The Small Molecule Therapeutics Design workflow involves a series of activities done in various applications to manage the V+R active learning process. Image Credit: BIOVIA, Dassault Systèmes
Using in silico capabilities, BIOVIA’s solution for Small Molecule Therapeutics Design adds an extra dimension to Drug Discovery by allowing researchers to virtually detect and enhance small therapeutic molecules before and in combination with physical testing.
AI enables medicinal chemists to rapidly produce ideas for new compounds to reach their target product profile quickly. The chemists can employ ML models and physics-based approaches designed and configured by in-house professionals without needing to learn how to build them.
This method helps decrease the number of physical trials needed to find a lead candidate. It also helps researchers boost the number of leads and discover unique, non-obvious molecules via de novo exploration of chemical space.
This process is complex as it necessitates numerous properties in a Target Product Profile (TPP) to be simultaneously optimized. A multi-objective optimization algorithm will balance properties such as off-target selectivity, ADME, on-target activity, developability, safety, and toxicity profiles, and even ease of synthesis to form new molecules with a higher chance of matching the TPP.
Approaches that are invaluable in the generative design process are pharmacophore scoring and docking simulations. These methods can be costly, but using them in a scalable cloud framework makes it possible to apply them to massive virtual chemistry data sets. These 3D approaches are vital for producing better quality molecules.
Molecular modeling and simulation methods enable computational chemists to assist design chemists by engineering and publishing extremely accurate models assembled for their particular areas of interest. These models can be life-cycled and managed in the cloud and need no involvement from IT or software developers.
Figure 3. (left) A candidate drug docked in a protein’s binding pocket; (right) a map of the intermolecular interactions between the protein and ligand. Image Credit: BIOVIA, Dassault Systèmes
Figure 4. The system helps you monitor the progress of the multi-objective optimization process, as it is balancing multiple properties that are often competing. Image Credit: BIOVIA, Dassault Systèmes
Figure 5. A cloud-based electronic lab notebook helps scientists to design, plan, record, and analyze experiments, draw conclusions, and document the outcome. Automated capturing of results, signatures, and countersignatures ensures IP protection. Image Credit: BIOVIA, Dassault Systèmes
The computerized virtual creation and testing of unique small molecules will Excellerate lead molecule design in advance of physical testing, making physical testing more targeted and decreasing drug discovery cycle times and costs.
BIOVIA’s solution for Small Molecule Therapeutics Design assists researchers’ workflows in the lab end-to-end. The researchers can effectively strategize, record, plan, and analyze physical experiments, derive conclusions, and record outcomes through an intuitive user interface.
It supports and records the creation, organization, and utilization of samples and lab materials, offering an instant inventory overview. Integrating data capture and analytics, experiment authoring, compound registration, and review guarantees the safe capture of essential data, documentation, and expert scientific knowledge.
This permits its reuse throughout projects and inside R&D communities and protects intellectual property (IP). Team members can easily detect biological and chemical substances and share the data across and within teams.
A team of researchers can work together and instantly contribute to the same experiment. Overall, it accelerates physical lab experimentation and assists teamwork and knowledge management.
BIOVIA offers an agile, integrated and robust solution for Small Molecule Therapeutics Design that integrates virtual and real operations in a collaborative cloud environment.
The synergy between in silico techniques for virtual identification and enhancement of compounds and physical experimentation at the bench significantly improves R&D productivity, helping teams to deliver safer, more effective treatments to patients more rapidly than ever before.
With the BIOVIA solution for Small Molecule Therapeutics Design, drug discovery teams can:
BIOVIA™ provides global, collaborative product lifecycle experiences to transform scientific innovation. Our solutions create an unmatched scientific management environment that can help science-based organizations create and connect biological, chemical and material innovations to Excellerate the way we live.
The industry-leading BIOVIA portfolio integrates the diversity of science, experimental processes and information requirements, end-to-end, across research, development, QA/QC and manufacturing. Capabilities include Scientific Informatics, Molecular Modeling/Simulation, Data Science, Laboratory Informatics, Formulation Design, BioPharma Quality & Compliance and Manufacturing Analytics.
BIOVIA is committed to enhancing and speeding innovation, increasing productivity, improving quality and compliance, reducing costs and accelerating product development for customers in multiple industries.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.
Strengthening educational support will lead to more career opportunities
October 13, 2022
Despite the rapidly growing Hispanic population in the United States, Hispanics only represent a small portion of health professions, making up 4.9 percent of medical and health professionals. Health occupational jobs are low paying with low mobility, while practitioners have substantially higher incomes with much more potential for advancement.
In Massachusetts, the median annual wage for healthcare support occupations is $39,353, while health diagnosis and treating practitioners make $103,723 annually. Hispanics make up 17.3 percent of health care support occupations and a mere 2.6 percent of health diagnosis and treating practitioners.
In the U.S., home care health aids play an essential role in the health care system, and these jobs are consistently in high demand. Health care support aids care for the elderly, disabled and other vulnerable populations in need of significant assistance. Home aids work long hours, which are often incredibly physically and emotionally demanding.
The home health aide profession is rooted in slave labor. As a result, this is an exploited and underappreciated workforce. Many healthcare occupational jobs have historically been excluded from U.S. labor laws, and they often lack the most basic rights and protections, including discrimination and harassment laws, the right to a safe workplace and a minimum wage.
Many healthcare occupational jobs do not require previous educational credentials, while most higher paying professions in healthcare require post-graduate degrees. Lack of education is a primary reason why Hispanic individuals comprise such an overwhelming number of occupational jobs and such a small percentage of more prestigious healthcare jobs with better pay and benefits. The lack of Hispanic students at colleges and nursing and medical schools largely limits the number of Hispanics entering healthcare professions.
The lack of Hispanics graduating with degrees can be confounded with the barriers Hispanic students face at institutions of higher learning, like the difficult transition to a new environment, underrepresentation on campuses among students and faculty, familial obstacles and lack of necessary support.
Many Hispanic students experience culture shock when beginning their educational career, as they must often adjust to a culture and lifestyle that is very unfamiliar to them. In many cases, emotional challenges arise as a result.
A disproportionate number of Hispanic students have experienced poverty, significant familial obstacles and other traumatic events. Many Hispanic students have responsibilities other students may not, such as caring for a family member or playing an essential role in financially supporting their family. These factors have direct impacts on their ability to succeed academically, socially and otherwise.
A family’s ability to fully understand their child’s educational journey and assist them if necessary is an important part of a student’s success. Many Hispanic students do not have family members who have attended college. This can often lead to a lack of familial support in their educational endeavors, which can exacerbate the factors that impede a Hispanic student’s success.
At many educational institutions in the U.S., Hispanic students are severely underrepresented. This makes it difficult for new students to find a community and network during their transition to a new environment.
At the University of Massachusetts, there is a lack of diversity especially notable in the small number of Hispanic students on campus. Last fall, 9.6 percent of the domestic undergraduate population identified as Hispanic. Hispanic students made up about 7.2 percent of the undergraduate degrees awarded in 2021, and approximately 9.4 percent of the degrees awarded by the College of Nursing.
There is also a lack of representation among faculty at academic institutions, which means less guidance and mentorship is available for minority students who rely on such support. At UMass, there is a lack of diversity among underrepresented groups of faculty members — Black, Hispanic and Native American/Alaska Native. In 2021, 77.3 percent of domestic faculty members identified as white.
We must commit to mitigating the major disparities in the healthcare workforce. First, the lack of Hispanic students attaining degrees must be addressed. In committing to admitting more Hispanic students, more Hispanic recruiters should work to reach minority communities. Increasing the admittance of Hispanic students should be met with an increase in an institution’s efforts to understand and guide these populations in their endeavors.
Strengthening a learning community should be done through expanding the available tutoring or peer advising opportunities. Advisors and faculty should work more closely with Hispanic students and their families to guide them through the obstacles faced by underrepresented groups.
Hispanic Americans are crucial to the healthcare workforce, yet they work some of the most burdensome jobs with very little yield. An investment in the educational opportunities available to Hispanic students is an investment in the future of Hispanic generations and the U.S. health care system.
Juliette Perez can be reached at [email protected]
To foster and promote opportunities for medical education, the Dubai Health Authority’s Medical Education and Research Department announced today that medical interns can receive training across government or private hospitals in the Emirate.
The move aims to provide a further impetus to the medical education programmes that the DHA offers medical students.
Awadh Seghayer Al Ketbi, Director-General of the Dubai Health Authority said: “People are the most important human resource in the health care delivery system, and we deeply value the contribution of every healthcare professional, providing them with continuous learning opportunities to ensure they are up-to-date with the latest advances in the field.
At the same time, to ensure a steady flow of highly trained medical professionals, we make sure we provide a wide-range of medical programmes for medical students. The move to open up opportunities for medical internships in the private sector, in addition to the government sector, aims to provide medical interns with a wide range of opportunities to pursue their medical education, and is in line with our strategic objectives for the growth and advancement of the health sector in the Emirate.”
He appreciated the private health sector’s response to this initiative, which will help in further advancement of the health sector.
Al Ketbi also highlighted that this is an excellent opportunity for interns to gain experience before they continue their further studies and begin serving community members.
Dr Wadeia Mohammad Sharief, Director of Medical Education and Research Department at the Dubai Health Authority said: “This initiative will help us continue our foray into strengthening medical education and training programmes, with the aim to empower interns to join speciality residency programs with competence.
Upon pursuing their 4 to 6 year residency programs, they will then become part of the high-quality medical talent of the health sector.”
Dr Sharief said that American hospital will receive 8 trainees, Medcare hospital will receive 28 trainees, Aster will receive 27 trainees, Saudi German will receive 10 trainees and Dr Sulaiman Al Habib will receive 8 trainees. The programme will begin in October this year.
She highlighted that those interested can email email@example.com or alternately apply through DHA’s online Sheryan system.